59.14
Genedx Holdings Corp stock is traded at $59.14, with a volume of 1.57M.
It is up +4.93% in the last 24 hours and down -39.21% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$56.36
Open:
$59
24h Volume:
1.57M
Relative Volume:
1.26
Market Cap:
$1.92B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-19.02
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
-12.03%
1M Performance:
-39.21%
6M Performance:
-23.98%
1Y Performance:
+191.04%
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
WGS
Genedx Holdings Corp
|
59.14 | 1.92B | 267.23M | -83.50M | -59.99M | -3.11 |
![]()
TMO
Thermo Fisher Scientific Inc
|
403.13 | 159.89B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
189.73 | 142.45B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
491.70 | 37.95B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
106.93 | 30.97B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IQV
Iqvia Holdings Inc
|
148.99 | 26.72B | 15.50B | 1.33B | 2.16B | 7.34 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-09-25 | Upgrade | Jefferies | Hold → Buy |
Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
Jul-10-24 | Initiated | Craig Hallum | Buy |
Jun-03-24 | Resumed | Jefferies | Hold |
Genedx Holdings Corp Stock (WGS) Latest News
GeneDx Shares Rise After Ratings Upgrade From Jefferies - marketscreener.com
GeneDx Holdings (WGS) Upgraded by Jefferies on Growth Prospects - GuruFocus
GeneDx upgraded to Buy from Hold on growth outlook - MSN
GeneDx stock upgraded at Jefferies on outlook (WGS:NASDAQ) - Seeking Alpha
Analyst Expectations For GeneDx Holdings's Future - Benzinga
This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga
Jefferies Upgrades GeneDx Holdings (WGS) - Nasdaq
Jefferies Upgrades GeneDx to Buy From Hold, $80 Price Target - marketscreener.com
GeneDx upgraded to Buy from Hold at Jefferies - TipRanks
GeneDx Holdings Corp. completed the acquisition of Fabric Genomics, Inc. - marketscreener.com
GeneDx Holdings Becomes Oversold (WGS) - Nasdaq
GeneDx Announces Completion of Fabric Genomics Acquisition - Business Wire
Envestnet Asset Management Inc. Purchases New Shares in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
Where are the Opportunities in (WGS) - news.stocktradersdaily.com
Best Momentum Stocks To Buy For May 5th - Barchart.com
Best Momentum Stocks to Buy for May 5th - TradingView
New Strong Buy Stocks for May 5th - Zacks Investment Research
Why Investors Were Avoiding GeneDx Holdings Stock This Week - AOL.com
Stamford genetic-testing firm GeneDx still searching for tenants to sublet part of HQ, shuttered CT lab spaces - Hartford Business Journal
With A 26% Price Drop For GeneDx Holdings Corp. (NASDAQ:WGS) You'll Still Get What You Pay For - simplywall.st
GENEDX HOLDINGS (WGS) Upgraded to Buy: Here's Why - MSN
GeneDx Holdings (WGS) Gets a Hold from Wells Fargo - The Globe and Mail
GeneDx plunges despite Q1 beat and guidance raise - MSN
GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates - MSN
GeneDx price target lowered to $78 from $105 at Wells Fargo - TipRanks
GeneDx Holdings (WGS) Receives Adjusted Price Target by Wells Fa - GuruFocus
GeneDx price target lowered to $100 from $115 at BTIG - TipRanks
GeneDx Holdings (WGS) Price Target Lowered by TD Securities | WG - GuruFocus
GeneDx stock target cut to $100 by BTIG, maintains Buy rating - Investing.com Nigeria
GeneDx Holdings (WGS) Receives Adjusted Price Target by Wells Fargo | WGS Stock News - GuruFocus
GeneDx earnings selloff a buying opportunity, says Craig-Hallum - Yahoo Finance
GeneDx (WGS) Price Target Reduced by TD Cowen Amid Strong Perfor - GuruFocus
GeneDx (WGS) Stock Decline Seen as Buying Opportunity | WGS Stoc - GuruFocus
GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2025 Earnings Call Transcript - Insider Monkey
GeneDx (WGS) Sees Price Target Cut But Retains Buy Rating | WGS Stock News - GuruFocus
Wells Fargo Adjusts Price Target for GeneDx (WGS) Amid Market Fl - GuruFocus
WGS Reports Strong Q1 Revenue, Outpaces Expectations | WGS Stock News - GuruFocus
GeneDx Reports Strong Q1 2025 Growth and Expansion Plans - TipRanks
GeneDx Holdings Corp. Q1 2025 Earnings Preview - MSN
Retail Buzz Swirls Around GeneDx As Shares Sink 43% Despite Earnings Beat - MSN
Retail Buzz Swirls Around GeneDx As Shares Sink 43% Despite Earnings Beat By Stocktwits - Investing.com India
GeneDx Holdings Corp. Reports Strong Earnings and Strategic Growth - TipRanks
GeneDx (WGS) Stock Decline Viewed as Buying Opportunity | WGS St - GuruFocus
GeneDx: A Diagnostic Company's Stock Takes a Hit Amidst Earnings Beat and Guidance Raise - RagingBull
Why GeneDx Holdings Stock Is Plunging Today - AOL.com
GeneDx Holdings earnings missed by $0.29, revenue topped estimates - Investing.com South Africa
Why GeneDx Holdings Stock Is Plunging Today - The Motley Fool
GeneDx stock plunges despite Q1 beat (WGS:NASDAQ) - Seeking Alpha
GeneDx (WGS) Stock Decline Viewed as Buying Opportunity | WGS Stock News - GuruFocus
GeneDx (WGS) Stock Decline Seen as Buying Opportunity | WGS Stock News - GuruFocus
Earnings call transcript: GeneDx Q1 2025 misses EPS, stock plummets - Investing.com
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Genedx Holdings Corp Stock (WGS) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Feeley Kevin | CHIEF FINANCIAL OFFICER |
Apr 29 '25 |
Option Exercise |
0.00 |
753 |
0 |
3,725 |
Feeley Kevin | CHIEF FINANCIAL OFFICER |
Apr 29 '25 |
Sale |
113.09 |
388 |
43,879 |
3,337 |
Stueland Katherine | Chief Executive Officer |
Apr 29 '25 |
Option Exercise |
0.00 |
3,874 |
0 |
5,594 |
Stueland Katherine | Chief Executive Officer |
Apr 29 '25 |
Sale |
113.09 |
2,154 |
243,596 |
3,440 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):